Related Experiment Videos
Isoniazid-induced pure red cell aplasia
The American Review of Respiratory Disease
|June 1, 1985
Summary
Pure red blood cell aplasia (PRCA) is a rare side effect of isoniazid (INH). Discontinuation of INH led to rapid anemia recovery in two patients, suggesting PRCA as a potential cause for unexplained anemia during INH treatment.
Area of Science:
- Hematology
- Pharmacology
- Infectious Diseases
Background:
- Isoniazid (INH) is a primary drug for tuberculosis prevention and treatment.
- Drug-induced anemia is a known but uncommon complication of various medications.
Observation:
- Two patients developed severe anemia during isoniazid therapy.
- One patient received INH preventive therapy; the other received combination therapy with INH and rifampin.
Findings:
- Both patients were diagnosed with pure red blood cell aplasia (PRCA).
- Anemia resolved rapidly upon discontinuation of isoniazid in both cases.
Implications:
- Pure red blood cell aplasia should be considered in the differential diagnosis of unexplained anemia in patients undergoing isoniazid therapy.
- Early recognition and withdrawal of isoniazid can lead to prompt recovery from drug-induced PRCA.